Sunday, January 24, 2021

Change Healthcare buys back pharmacy unit, sells analytics business

Months after splitting off from McKesson Corp., Change Healthcare made two deals to buy back its pharmacy business and sell its analytics business. The company bought back eRx Network, its former pharmacy unit, for $212.9 million plus cash on the balance sheet. The deal would reincorporate eRx Network, which serves more than 59,000 pharmacies,...

Startup gets FDA clearance for device that can monitor baby’s heart rate

Physicians will be able to prescribe a wearable sensor band to help women monitor a fetus’ health in the third trimester of a pregnancy. Nuvo Group, a Tel Aviv-based medical device company, received 510(k) clearance from the Food and Drug Administration for its sensor band. The monitoring platform, called INVU, is worn on the...

Leading Jersey Legal Practice Drives Document Innovation Through Zylpha

Jersey
Respected Jersey based specialist family law practice Claire Davies, Advocate has chosen electronic document bundling software from leading legal software innovator Zylpha (www.zylpha.com). The move has proved extremely timely as the island’s Royal Court (Family division) is now actively encouraging the use of electronic legal document bundles...

45 days after national emergency declared, retail execs promise to ramp up Covid-19 testing

Medical workers swab patients for Covid-19 at the drive-in center at ProHealth Care on March 21 in Jericho, New York. More than a month after they first announced plans to offer Covid-19 tests in parking lots, the heads of several retailers returned to the White House Rose Garden to promise more testing sites. When President...

From Data to AI: How these 4 tech trends are reshaping healthcare

Healthcare is undergoing an incredible digital transformation that is altering virtually every aspect of the industry, making the once-impossible probable and reorienting everything from diagnosis and treatments. It’s evident that, in the years ahead, this sector will continually and increasingly be defined by the development and implementation of new technologies. Healthcare providers indicate as...

Life sciences in a changing world: Startup outlook through 2020

Life sciences startups have always been on a mission to improve human health through innovation. The global impacts of the COVID-19 crisis have made the importance of that work clearer than ever. Whether its work directly relates to virus relief efforts or not, every startup in this industry has felt the impact of...

CMS changes to Stark Law appear largely positive, experts say

CMS recently finalized changes to Stark Law regulations that will go into effect Jan. 19, and healthcare law experts generally believe that these changes will make it easier for hospitals and physician groups to comply with the law, and provide them with greater flexibility as they move toward value-based care. Stark Law, also known...

EverCommerce buys healthcare communication platform Updox

close up of male hands nightlight smartphone
EverCommerce, which provides marketing, business management and customer retention solutions to businesses in the service sector, has purchased Updox, a healthcare communication platform for both in-person and virtual care. Updox will join EverCommerce’s portfolio of health services companies and solutions, which includes cloud-based medical billing, specialty EHR, practice management and revenue cycle management software...

As Covid-19 hinders clinical trial operations, research staff are finding themselves out of work

People waiting to get tested at Elmhurst Hospital Center in Queens, New York City, which has been flooded with patients due to Covid-19 With Covid-19 overwhelming hospitals that would ordinarily serve as sites to test their product candidates, numerous drugmakers have announced plans to wind down clinical trial operations, both to free up capacity...

Is hydroxychloroquine hype hampering enrollment in Gilead’s Covid-19 drug trials?

Last week, Gilead Sciences made significant adjustments to the Phase III trials of its drug remdesivir in hospitalized patients with Covid-19, leading to some speculation that the company may have lowered its expectations for the drug. Two investigators in the trials weighed in on what the changes could mean, as well as some...
0FansLike
0FollowersFollow

Must Read